MEM 0.00% 0.7¢ memphasys limited.

Ann: Full Year Statutory Accounts, page-2

  1. 440 Posts.
    lightbulb Created with Sketch. 1
    "Outlook for 2018
    The development of the next generation Felix device is expected to be key value driver for the company over the next 12 months. As reported post reporting date on 7 August 2017, testing of the current new re-usable cartridges demonstrated that cartridges efficiently separate viable sperm from ejaculate in healthy human males.

    The ensuring development steps entail:
    - The testing and optimisation of the reusable cartridges, initially with Professor John Aitken’s research group at the University of Newcastle.
    - Further testing using clinical ejaculate samples by our UNSW IVF clinical partner under the guidance of Professor John Aitken.
    - Use of clinical test results to guide the development of the final fully disposable cartridge.
    - Clinically testing and publishing results on the utility of the next generation prototype device containing the fully disposable cartridge by Key Opinion Leaders in leading global IVF centres."

    Just like an old rusty Landcruiser ute, there might be some life in this old girl.

    Back in the bottom drawer for now
    Last edited by Sprinter04: 29/09/17
 
watchlist Created with Sketch. Add MEM (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $9.679M
Open High Low Value Volume
0.7¢ 0.7¢ 0.6¢ $3.482K 531.7K

Buyers (Bids)

No. Vol. Price($)
10 2963896 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 569603 2
View Market Depth
Last trade - 15.55pm 26/06/2024 (20 minute delay) ?
MEM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.